Dr. Ruben Mesa, director of the Mays Cancer Center, has been teaching fellow physicians about the treatment of myelofibrosis, one of his research and treatment areas.
He discusses the current challenges in the treatment landscape for researchers treating myelofibrosis (MF) and how a greater understanding of why patients relapse will help investigators overcome these challenges.